Merck KGaA/MRK
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Merck KGaA
Ticker
MRK
Sector
Healthcare
Trading on
XETRA
Industry
Pharmaceuticals
Headquarters
Darmstadt, Germany
Employees
62,345
Website
www.emdgroup.com
Merck KGaA Metrics
BasicAdvanced
€65B
Market cap
24.03
P/E ratio
€6.26
EPS
0.68
Beta
€2.20
Dividend rate
1.46%
Dividend yield
Price and volume
Market cap
€65B
Beta
0.68
Dividend rate
€2.20
Financial strength
Current ratio
1.29
Quick ratio
0.721
Long term debt to equity
27.866
Total debt to equity
35.456
Dividend payout ratio (TTM)
40.93%
Interest coverage (TTM)
13.35%
Management effectiveness
Return on assets (TTM)
4.57%
Return on equity (TTM)
10.07%
Valuation
Price to earnings (TTM)
24.03
Price to revenue (TTM)
3.14
Price to book
2.32
Price to tangible book (TTM)
19.5
Price to free cash flow (TTM)
33.33
Dividend yield (TTM)
1.46%
Growth
Revenue change (TTM)
-6.75%
Earnings per share change (TTM)
-16.08%
3-year revenue growth
5.37%
3-year earnings per share growth
6.11%
3-year dividend per share growth
16.26%
What the Analysts think about Merck KGaA
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Merck KGaA stock.
Merck KGaA Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Merck KGaA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Merck KGaA News
AllArticlesVideos
Buy These 7 Dividend Stocks and Hold Forever
24/7 Wall Street·17 hours ago
Global Bioreactors Market Forecast Report 2024-2035 with Key Players Profiles of Applikon Biotechnology, Bionet, Cytiva, Eppendorf, Merck, Sartorius, Solaris Biotech, Solida Biotech and LABAO
GlobeNewsWire·5 days ago
Merck Stock Is Slipping. A CDC Committee Considers Pneumococcal Vaccines.
Barrons·6 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Merck KGaA stock?
Merck KGaA (MRK) has a market cap of €65B as of July 03, 2024.
What is the P/E ratio for Merck KGaA stock?
The price to earnings (P/E) ratio for Merck KGaA (MRK) stock is 24.03 as of July 03, 2024.
Does Merck KGaA stock pay dividends?
Yes, the Merck KGaA (MRK) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is €2.2 and the yield is 1.46%. Merck KGaA has a payout ratio of 40.93% on a trailing twelve-month basis.
When is the next Merck KGaA dividend payment date?
The next Merck KGaA (MRK) dividend payment date is unconfirmed.
What is the beta indicator for Merck KGaA?
Merck KGaA (MRK) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Merck KGaA stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.